Company Description
Icoreconnect (OTC Link: ICCT) is classified in the health information services industry within the Services-prepackaged Software sector.
ICCT has declined 99.9% over the past year. Shares last traded at $0.0011.
This page collects what Stock Titan holds for ICCT, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Icoreconnect (ICCT) stock last closed at $0.0011. Over the past 12 months, the stock has lost 99.9%.
ICCT Rankings
Latest News
Icoreconnect has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include stock split, partnership, acquisition, management. View all ICCT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Icoreconnect (ICCT) currently stands at 16.1 thousand shares, representing 0.0% of the float. Since August 2025, short interest has decreased by 29.5%. This relatively low short interest suggests limited bearish sentiment. The 5.8 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Icoreconnect (ICCT) currently stands at 5.8 days, up 130.8% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 48.6% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 22.6 days.
ICCT Company Profile & Sector Positioning
Icoreconnect (ICCT) operates in the Health Information Services industry within the broader Services-prepackaged Software sector and is listed on the OTC Link.
Investors comparing ICCT often look at related companies in the same sector, including Ecoplus Inc (ECPL), Newtopia (NEWUF), Cardiocomm Solut (EKGGF), EvokAI Creative (OKAIF), and Mednow (MDNWF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ICCT's relative position within its industry.